Gene Therapy

Forge Editing is our proprietary gene-editing technology which we pioneered in a range of bacterial species. We are currently working to adapt the technique to work in human cells where we believe it can be a safer alternative to existing gene editing methods.

We are seeking investment to fund this development work as well as seeking non-dilutive grant funding. If you are interested in learning more, investing, or partnering with us please contact enquiries@forgegenetics.com.